Viewing StudyNCT06351332



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06351332
Status: SUSPENDED
Last Update Posted: 2024-06-20
First Post: 2024-04-02

Brief Title: ZAP-IT ZN-c3 Carboplatin Pembrolizumab in MTNBC
Sponsor: Filipa Lynce MD
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Breast Cancer Female
Triple Negative Breast Cancer
Hormone Receptor Negative Malignant Tumor Breast Triple
HER2-negative Breast Cancer
Keywords:
Name View
HER2-negative Breast Cancer View
Breast Cancer View
Breast Cancer Female View
Triple Negative Breast Cancer View
Hormone Receptor Negative Malignant Tumor Breast Triple View